TriReme raises $17M in Series D funding
TriReme Medical, which develops catheters and stents for treating vascular disease, has raised $17 million in Series D financing. The funding was led by new investor Bio*One Capital (a subsidiary of Singapore based EDB Investments) as well as return investors Three Arch Partners and Adams Street Partners. The money will be used to ramp-up commercial activities, fund R&D, and seek regulatory approval for products in the US, Japan, and China.
11 October 2010•3 mins read
